Our study revealed that the positive “super T2-FLAIR mismatch sign” was a better prognostic marker in patients with non-enhancing astrocytoma, IDH-mutant WHO grade 2 and 3. The gene discussed is IDH2; the disease is astrocytoma (excluding glioblastoma).